Arbutus Biopharma Corporation
ABUSNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $829.38M
- P/E (TTM)
- 5.42
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.50$5.45
- Volume (live)
- -
- Avg. volume (3M)
- 6.51M
Arbutus Biopharma (ABUS) Stock Price & Financial Analysis
Arbutus Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.12 - $4.22 |
|---|---|
| 52-Week High | $5.45 |
| 52-Week Low | $3.50 |
| Open | $4.17 |
| Volume (last close) | 2.03M |
| Average Volume (3M) | 6.51M |
| Revenue (TTM) | 181.72M |
|---|---|
| Net Income (TTM) | 153.05M |
| Free Cash Flow (TTM) | -24.63M |
| EPS (TTM) | $0.79 |
| Profit Margin | 84.23% |
| Operating Margin | 81.01% |
| Return on Equity (ROE) | 59.16% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 829.38M |
|---|---|
| Shares Outstanding | 197.47M |
| P/E Ratio (TTM) | 5.42 |
| Price to Sales (P/S) | 4.56 |
| Price to Book (P/B) | 3.21 |
| EV/EBITDA | 5.33 |
| 50-Day MA | $4.79 |
|---|---|
| 200-Day MA | $4.51 |
| 1-Year Change | −1.64% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Arbutus Biopharma at a Glance
As of the Oct 23, 2026 close, Arbutus Biopharma (ABUS) has a market capitalization of $829.38M. The stock trades at 5.4× trailing earnings and 4.6× sales. Over the trailing twelve months it earned $153.05M on revenue of $181.72M (a 84.2% profit margin) and burned $24.63M of free cash flow. Revenue grew 1078.8% year over year.
As of its latest reported balance sheet, it holds $19.17M in cash and securities against $3.63M of debt, a net cash position of $15.55M.
Arbutus Biopharma does not currently pay a dividend.
The share price is down 1.6% over the past year. At $4.20 (the Oct 23, 2026 close) it sits within its 52-week range of $3.50 to $5.45, below its 200-day moving average of $4.51.
Frequently Asked Questions About Arbutus Biopharma
What is the current stock price for ABUS?
As of the Oct 23, 2026 close, ABUS stock trades at $4.20. The 52-week range is $3.50–$5.45, with a day range of $4.12–$4.22.
What is the P/E ratio for ABUS?
As of the Oct 23, 2026 close, Arbutus Biopharma's trailing twelve-month (TTM) P/E ratio is 5.4, meaning investors pay $5.4 for every $1 of annual earnings. Arbutus Biopharma operates in the Healthcare sector.
Does ABUS pay dividends?
Arbutus Biopharma does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABUS?
Analyst ratings and recommendations for ABUS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ABUS?
As of the Oct 23, 2026 close, Arbutus Biopharma's market capitalization is $829.4M, classifying it as a small-cap company. Arbutus Biopharma operates in the Healthcare sector within the Biotechnology industry.